Last edition
News about "The Indian Pharmacopoeia Commission (IPC)"
IPC adds 9 new IP impurities standards
The Indian Pharmacopoeia Commission (IPC) has added 9 new IP impurities standards which includes Bromhexine Hydrochloride Impurity C, Cabergoline Impurity A, Cilostazol Impurity B, Citalopram Impurity B, Fosinopril Impurity A, o-toluene sulfonamide, p-toluene sulfonamide, Tributyl o-acetyl citrate/Acetyl Tributyl citrate, Vildagliptin Impurity D
The Indian Pharmacopoeia Commission IPC | 07/12/2021 | By Darshana | 642
The programme will cover pharmacovigilance: basics, objectives & methods, ADRs: Understanding, prevention & reporting, understanding about individual case safety reports (ICSRs), Materiovigilance Programme of India and causality assessment & quality review, signal detection and assessment, and adverse events following immunization (AEFI)
The Indian Pharmacopoeia Commission (IPC) | 18/10/2021 | By Darshana | 323
IPC sounds safety alert against hepatitis C drug sofosbuvir
The Indian Pharmacopoeia Commission (IPC), which is the National Coordination Centre (NCC) for Pharmacovigilance Programme of India (PvPI) has flagged a drug safety alert revealing that sofosbuvir which is used in combination with other medicinal products for the treatment of chronic hepatitis C in adults is associated with Stevens-Johnson Syndrome
The Indian Pharmacopoeia Commission (IPC) | 04/09/2021 | By Darshana | 260
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy